The effects of endocrine disruptors on the male germline: an intergenerational health risk

2021 ◽  
Author(s):  
Marta Lombó ◽  
Paz Herráez
Keyword(s):  
Health Risk ◽  
Endocrine Disruptors ◽  
Male Germline

Cosmetics as endocrine disruptors: are they a health risk?

2015 ◽  
Vol 16 (4) ◽  
pp. 373-383 ◽  
Author(s):  
Polyxeni Nicolopoulou-Stamati ◽  
Luc Hens ◽  
Annie J. Sasco
Keyword(s):  
Health Risk ◽  
Endocrine Disruptors

Severe Drooling and Treatment With Botulinum Toxin

2012 ◽  
Vol 21 (1) ◽  
pp. 15-21
Author(s):  
Merete Bakke ◽  
Allan Bardow ◽  
Eigild Møller
Keyword(s):  
Botulinum Toxin ◽  
Side Effects ◽  
Health Risk ◽  
Flow Rate ◽  
Clinical Evidence ◽  
Acetylcholine Release ◽  
Psychosocial Problems ◽  
Rate Reduction ◽  
Local Inhibition ◽  
Surgical Treatments

Severe drooling is associated with discomfort and psychosocial problems and may constitute a health risk. A variety of different surgical and non-surgical treatments have been used to diminish drooling, some of them with little or uncertain effect and others more effective but irreversible or with side effects. Based on clinical evidence, injection with botulinum toxin (BTX) into the parotid and submandibular glands is a useful treatment option, because it is local, reversible, and with few side effects, although it has to be repeated. The mechanism of BTX is a local inhibition of acetylcholine release, which diminishes receptor-coupled secretion and results in a flow rate reduction of 25–50% for 2–7 months.

Sign in / Sign up

Export Citation Format

Share Document